The AeroDR LT is a smart wireless digital radiography (DR) solution that can be used in most rooms and portable X-ray systems. The flat panel detector delivers added economic value by extending the life and value of existing radiology rooms and solutions. AeroDR LT is easy to carry and easy to position with its light weight (5.5 lbs.) and grip strips right on the panel—helping increase both patient satisfaction and technologist productivity.

IBA announced that longtime customer and research partner Penn Medicine has upgraded the equipment of its Roberts Proton Therapy Center with the latest innovations in proton therapy treatment. This upgrade to the newest technologies will allow Penn Medicine’s staff to continue to offer top-level proton radiation therapy services to an increasing number of patients and to further advance the clinical application of proton therapy.

Mach7 Technologies and 3D Medical Limited announced yesterday they have signed a definitive agreement to merge together. The merger will provide access via public capital markets for Mach7 while preserving corporate self-determination with regard to mission and product roadmap. Upon approval and completion of the agreement, the merged entity will be publicly listed on the Australian stock exchange (ASX) and will trade as "Mach7 Technologies Ltd."

Carestream Health earned the top rating in MD Buyline’s Market Intelligence Briefing (Q3 2015) for both portable and room-based digital X-ray systems for the third time this year. The company’s DRX-Revolution mobile X-ray system and its DRX-Evolution and DRX-Ascend systems scored high marks from healthcare providers for performance, reliability, installation and service quality.

Healthcare technology company MphRx will debut a new platform at the Radiological Society of North America (RSNA) 2015 annual meeting that enables transmission of detailed patient forms, images and records from any computer for review by providers and automated ingestion into an EMR, PACS or RIS.

University of Missouri, EBUS-TBFNA, lung cancer diagnosis

University of Missouri researchers have developed a new scoring system for a common lung cancer diagnostic test that may help physicians better understand the risk for malignancy when evaluating patients.

New data from clinical trials conducted at Penn Medicine’s Robert Proton Therapy Center demonstrate the technology's potential advantages over conventional radiation, including less side effects and survival in some cases, for several harder-to-treat tumors. This includes pancreatic, late-stage non-small cell lung and chordoma and chondrosarcoma, two rare cancers found in bone or soft tissue.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now